SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-005589
Filing Date
2019-06-10
Accepted
2019-06-10 16:11:42
Documents
58
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q nxtc-20190331x10q.htm 10-Q 1590917
2 EX-31.1 nxtc-20190331ex311dfc776.htm EX-31.1 13473
3 EX-31.2 nxtc-20190331ex312220b5e.htm EX-31.2 12389
4 EX-32.1 nxtc-20190331ex32149c2a1.htm EX-32.1 13671
  Complete submission text file 0001558370-19-005589.txt   4687860

Data Files

Seq Description Document Type Size
5 EX-101.INS nxtc-20190331.xml EX-101.INS 798320
6 EX-101.SCH nxtc-20190331.xsd EX-101.SCH 33882
7 EX-101.CAL nxtc-20190331_cal.xml EX-101.CAL 37895
8 EX-101.DEF nxtc-20190331_def.xml EX-101.DEF 115227
9 EX-101.LAB nxtc-20190331_lab.xml EX-101.LAB 312503
10 EX-101.PRE nxtc-20190331_pre.xml EX-101.PRE 233523
Mailing Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705
Business Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705 240-399-4900
NextCure, Inc. (Filer) CIK: 0001661059 (see all company filings)

IRS No.: 475231247 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38905 | Film No.: 19888713
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1